Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 6/20 | 0.71 |
| ▸ | CCKBR | P32239 | 4/20 | 0.67 |
| ▸ | NMBR | P28336 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8198630 | 0.95 | CCKBR (0.65) | TACR1CCKBRNMBR | |
| SCHEMBL8197623 | 0.92 | TACR1 (0.72) | TACR1CCKBRNMBR | |
| SCHEMBL8197613 | 0.92 | TACR1 (0.72) | TACR1CCKBRNMBR | |
| SCHEMBL8200385 | 0.90 | TACR1 (0.65) | TACR1CCKBRNMBR | |
| SCHEMBL8203281 | 0.90 | CCKBR (0.67) | TACR1CCKBRNMBR | |
| SCHEMBL8197980 | 0.88 | CCKBR (0.62) | TACR1CCKBRNMBR | |
| SCHEMBL8937170 | 0.87 | TACR1 (0.72) | TACR1CCKBRNMBR | |
| SCHEMBL8850617 | 0.85 | CCKBR (0.62) | TACR1CCKBRNMBR | |
| SCHEMBL8101027 | 0.85 | CCKBR (0.62) | TACR1CCKBRNMBR | |
| SCHEMBL6892425 | 0.83 | CCKBR (0.78) | CCKBRNMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1000930-A2 | Tachykinin antagonists | WARNER-LAMBERT COMPANY (US) | 2000-05-17 | — | — | EP | disclosed |
| US-5594022-A | CARBAMATES | WARNER-LAMBERT COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| EP-0655055-A1 | TACHYKININ ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1995-05-31 | — | — | EP | disclosed |
| WO-1994004494-A1 | TACHYKININ ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1994-03-03 | — | — | WO | disclosed |